Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GLI1 | P08151 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GLI2 | P10070 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3947990 | 1.00 | PTPN1 (0.41) | PTPN1GLI1CYP3A4GLI2 | |
| SCHEMBL2905113 | 0.76 | — | — | |
| SCHEMBL2900309 | 0.76 | — | — | |
| SCHEMBL2905111 | 0.76 | — | — | |
| SCHEMBL1269326 | 0.76 | — | — | |
| SCHEMBL12475808 | 0.71 | PTPN1 (0.50) | PTPN1GLI1CYP3A4GLI2 | |
| SCHEMBL30105449 | 0.71 | PTPN1 (0.50) | PTPN1GLI1CYP3A4GLI2 | |
| SCHEMBL12345008 | 0.70 | PTPN1 (0.31) | PTPN1 | |
| SCHEMBL22148715 | 0.69 | — | — | |
| SCHEMBL368085 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090043065-A1 | Singlet oxygen oxidized materials and methods of making and using same | FINA TECHNOLOGY, INC. | 2009-02-12 | — | — | US | disclosed |
| US-6875518-B2 | Ruthenium film, ruthenium oxide film and process for forming the same | JSR CORPORATION (JP) | 2005-04-05 | — | — | US | disclosed |
| US-20030008157-A1 | Rutenium film rutenium oxide film, and method for formation thereof | JSR CORPORATION (JP) | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008157-A1 | Rutenium film rutenium oxide film, and method for formation thereof | LPO, SCO2, RNF5 | PTPN1 4053/4885GLI1 2732/4885CYP3A4 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.